They hope that it might result in the development of a vaccine for C eventually.

It could trigger pelvic inflammatory disease and result in scarring of the Fallopian tubes leading to infertility and higher threat of ectopic pregnancy. The study was completed at the Molecular Microbiology Group, at the University of Southampton, with the Division of Virology, at the Ben Gurion University of the Negev, in Israel. Professor Ian Clarke, from the University of Southampton, says: That is a very significant progress in the analysis of chlamydia and we are proud to become the first visitors to attain this.The various other four had received mixed kidney and bone marrow transplantation in a medical trial and stopped taking immunosuppressants eight weeks after medical procedures. CKBMT, an experimental therapy, may produce an immune declare that combines components of both the recipient's and donor's immune systems. ‘Our studies show that CKBMT induces tolerance of the transplanted organ with no need for long-term immunosuppressants. But we didn't understand the mechanism behind this tolerance,’ stated Dr. Sykes, who helped develop CKBMT in the first 2000s, as part of a Harvard University-Massachusetts General Medical center team. Related StoriesWider geographic posting of pediatric donor lungs can increase transplant rates for young U.S.